Bio ETF’s

By alanh, April 7, 2015

This thread is designed to allow investors to discuss the nature, strategies, tactics and stocks content of Bio ETF’s.
Before getting too engrossed in detail, please think about how we can create a structure for how to do this. I will publish a list of ALL known ETF’s. No one person could handle all the mentions within all the ETF’s on that list, so we will need a set of volunteers to adopt just one of them and regularly monitor it. No passengers here, I hope.
Rgs
Alan

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

154
Share your thoughts...

avatar
41 Comment threads
113 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
22 Comment authors
Benny Hillhendrixnuzzlesarch1SoGiAmRao Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.

KennyG
Member
πŸ‘3530
KennyG

Here is a new interesting bio index fund that is premiering today. I think it is something that I may consider buying into. I will also post in the new thread: A new stock index is debuting Tuesday to track the performance of companies developing cancer immunotherapies. The Loncar Cancer Immunotherapy Index (LCINDX) is an equal-weighted basket of 25 pharmaceutical and biotech companies developing (or already marketing) drugs which use the body’s own immune system to target and kill cancer cells. “The goal of the Cancer Immunotherapy index is to give investors a better understanding of the immunotherapy sector by… Read more Β»

Add a Topic
5971
Add a Topic
3397
Add a Topic
3397
biggdan
Member
πŸ‘62
biggdan

Some interesting thoughts on Bio from one of the best chartists I’ve found:
http://blog.kimblechartingsolutions.com/2015/04/bio-tech-key-support-test-in-play-following-reversal-pattern/
Worth keeping an eye on for sure.

arch1
Member
πŸ‘7784

I have been taking look at $xbi which tracks bio stocks on Standard and Poors as I have traders spiders in past,,SPDRS,,, although not in Bio. It has risen from $120.00 range to $220.00
in the last year,,,near double but has dropped and gained in last few days like its either going to break higher still or correct. I have not found yet which stox it trax, altho it just occurred to me to googlr SP BioTec h or similar. Will add more later. frank

jer_vic
Member
πŸ‘338
jer_vic

$XBI

https://www.spdrs.com/product/fund.seam?ticker=xbi
If you go to the Holdings tab, you can see the top ten list, and a tiny link to get the entire list of holdings via an Excel spreadsheet:
https://www.spdrs.com/site-content/xls/XBI_All_Holdings.xls?fund=XBI&docname=All+Holdings&onyx_code1=1286&onyx_code2=1718

Top ten holdings (as of Apr. 6, 2015 )
Dyax Corp. 1.75%
Esperion Therapeutics Inc. 1.43%
Prothena Corp. Plc 1.43%
Inovio Pharmaceuticals Inc. 1.36%
Auspex Pharmaceuticals Inc. 1.34%
Amicus Therapeutics Inc. 1.26%
ImmunoGen Inc. 1.25%
Orexigen Therapeutics Inc. 1.17%
United Therapeutics Corporation 1.15%
MiMedx Group Inc. 1.12%

arch1
Member
πŸ‘7784

I found linkhere

http://www.etfchannel.com/lists/?a=stockholdings&issuer=&symbol=XBI&sortby=&reverse=&rpp=20&start=0

any of those we follow are here in $xbi holdings including many unfamiliar to me..This looks like a good site to search from for other ETF holdings,,,I noticed they had a list headed be top ten insider holders.

Add a Topic
900
JoeS
Irregular
πŸ‘1768
JoeS

Frank was it you, Scorpio or Frenchy that brought up XPH when you were discussing a month or so ago? The chart for 6 months, YTD, 1yr, 2yr and 5yr are very impressive. I bought some back then. The “Joe bought some” chart is the only one that does not look like this ( / ) , but looks more like this ( \ )

biotechlong (btl)
Member
πŸ‘2793

Joe,
Here is an excerpt from my recent (March) post re ETFs – written in reply to John King’s inquiry:

“For those individuals who are somewhat risk averse – but nevertheless interested in investing in the biotech sector, a quality ETF such as SPDR S&P Pharmaceuticals (NYSE: XPH) may be a good fit. This is a non-leveraged exchange-traded fund (ETF) composed of some of the biopharma industry’s leading firms and a smattering of aggressive small caps.”

Add a Topic
900
Add a Topic
900
arch1
Member
πŸ‘7784

Lawrence Heres to you…I have not done anything ETF in some time,,,,,,,,It is looking to me that perhaps I should have as ,if given my choice of five of the top ten i would likely pick the bottom two to buy. πŸ™‚ frank

Add a Topic
900
hendrixnuzzles
Member
πŸ‘9951

They have 99 holdings. The strategy of the fund is equal weight so the larger holdings show what stocks have recently run up from their last adjustment. It does not reflect any opinion of the fund managers.

Remember that they are just a mirror of the NASDAQ stock population, they do not claim that their holdings are based on anything other than the company being in the sector and listed in the NASDAQ.

Add a Topic
5971
hendrixnuzzles
Member
πŸ‘9951

Hi Benny,

Happy to help, will dissect/cover XBI.

I do not normally use ETFs unless it is in a sector I am clueless about. In biotech would much rather make selections from informed discourse (that is, Stock Gumshoe), and your plan to pick the brains of the ETF managers is just what I like to do.

The picks and ideas highlighted in this thread will be an interesting counterpoint to the ETF holdings.

Long NVS, PFE, CMVLF; and now ZFGN, MEIP, PARN, and GNFTF thanxs to the Shoe.
Got a regular mutual fund going in biotech.

Add a Topic
5971
Add a Topic
900
Add a Topic
900
hendrixnuzzles
Member
πŸ‘9951

$XBI I just noticed that Frank already follows this one. So if he want to cover it going forward I’ll give it up for another. But this is what I found on XBI: GENERAL: ETF, open end, long only, fund, equal weight, 99 positions. Morningstar rating 4 stars. 1 yr growth +60%. Small cap 2.2 billion. TECHNICAL: Frank noted its recent growth. The chart went positive in June 2014 and has been an extended uptrend. There was a blow-off top in March 2015 that hit a high of 244. The price now seems to be consolidating above the 50 day… Read more Β»

Add a Topic
900
Add a Topic
1823
Add a Topic
5916
arch1
Member
πŸ‘7784

Larry I really did not volunteer to follow $XBI ,,,I just checked on it because it was a SPDR. as I have not done anything with an ETF in sometime. I am notoriously undependable for performing any meaningful work as various factors affect what I am able to do day to day. The report you just gave is what we need to decide if we give weight to one or more ETF’s. If you want to take on this chore and the criticism of those who do nothing I wish you God Speed and Best Wishes. πŸ™‚ πŸ™‚ :),,,,3 smiles… Read more Β»

Add a Topic
900
hendrixnuzzles
Member
πŸ‘9951

Thanks, Frank, just didn’t want to step on your toes if you were going to sign up for it.
Thanks for the kind words. Best to you

hipockets
Member
πŸ‘1233

Just found this ETF Gummy StartUp. I’ve held IBB (the iShares Nasdaq Biotechnology ETF) for around two years, so I will report on it in the near future.

Along the same line, another idea might be to look at venture capitalists specializing in biotech. I’ll look into that, too.

Add a Topic
900
Add a Topic
900
hendrixnuzzles
Member
πŸ‘9951

Because of how it is structured (equal weight) XBI does not look especially suited to our purposes. However I will start picking through their holdings anyway to see if I can find anything.

I would say that this looks like a good ETF for those who want a one click entry to the sector when and if you can get it close to NAV.

Add a Topic
900
hendrixnuzzles
Member
πŸ‘9951

$DYAX..number 2 in XBI This stock is overweight in the XBI because it just shot up 55% on FDA approval for safety and fast track designation for “rare hereditary disease” HAE which dumb laymen like me have never heard about. Also yesterday had a stock offer @ $ 27 and raised a bunch of money. http://www.marketwatch.com/story/dyax-shares-jump-40-on-best-in-class-potential-for-new-drug-2015-03-31 Didn’t do any fundamental research since they only have one approved drug and most of the future vigorish will be in this new thing, which I have no idea how to forecast. They also highlight a “phage library” of different peptides and fancy molecules… Read more Β»

Add a Topic
5971
Add a Topic
3022
Add a Topic
5971
SoGiAm
Member
πŸ‘11373

Sheet2!N8=HYPERLINK(“http://www.stockgumshoe.com/2014/05/microblog-hepatitis-with-a-c-right-now-someone-you-know-has-it-and-doesnt-know/#comment-N831575015″,”comment”) Best-Ben

ScorpioRising
Member
πŸ‘1019
ScorpioRising

Speaking of looking at biotech ETF’s for ideas, do you guys recall Doc’s posts in the Receptos thread? The Doc liked ISI Evercore’s Dr. Mark Schoenebaum. I can’t seem to find their picks, do you have to pay for their research?

http://www.stockgumshoe.com/2015/01/the-long-case-for-receptos/#comment-4192528

“The best biotech callers overall (after SG of course) are RBC, CS, BMO, ISI. DB would be better if they booted Robyn Karnauskas…she is just a master of the obvious. She used to hit it off with Melissa Lee on CNBC and now I think even Melissa realizes she’s a dunce.”

Add a Topic
372
arch1
Member
πŸ‘7784

Scorpio do you know which groups those initials represent,,,It seems you have identified
ISI Evercore or should I try to search them out,,,or have others already done so??

ScorpioRising
Member
πŸ‘1019
ScorpioRising

Off the top of my head, RBC is RBC capital management, CS is Credit Suisse, DB is Deutche Bank, BMO escapes me.

arch1
Member
πŸ‘7784

Looks to me those are for the big fish or whales,,,,not minnows like me,,,or perhaps i should be with the krill. I suspect their research comes with a substantial price.

ScorpioRising
Member
πŸ‘1019
ScorpioRising

BMO = BMO Capital Markets?

v4t1n4
Member
πŸ‘49

BMO = BMO Capital Markets? = Bank of Montreal? Non?

jer_vic
Member
πŸ‘338
jer_vic

Oui, BMO == Bank of Montreal. Not sure what specific aspect Dr. KSS was referring to, but probably Capital Markets.

Add a Topic
3932
arch1
Member
πŸ‘7784

ISI has morphed into Evercore,,,,an investment banking advisory group,,,,,,subscription sounds spendy as you cannot see their fees unless you give them Email so Sales sharks can put the pitch to you.

allisondbl
Member
πŸ‘712
allisondbl

Dr. KSS DOES like Schoenebaum and since I’m not paying for Evercore’s picks – they have clients and they charge for their insight – what I do is have a running up-to-the-minute google alert for him so that at least as soon as he or someone puts information into the netiverse with his name attached, I get it. As to information on ISI Evercore and Schoenebaum:

http://www.evercore.com/Investment-Banking/institutional-equities-research/fundamental-health-care

Add a Topic
3932